Elazzouzi Amy — SEC Form 4 filings
SEC reporting owner CIK 2042910. 11 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-10-29 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 8 filings — 22,603 shares, $137,792 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 7,722 shares @ $6.70 ($51,737) in Aura Biosciences, Inc., filed 2025-08-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aura Biosciences, Inc. (AURA) | SVP, Finance & PAO | 11 | — | 8 legs · 22,603 sh · $137,792 | 20 |
Form 4 filings — Elazzouzi Amy
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 23,540 @ $0 · Grant/award (A): 46,460 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 44,528 @ $0 · Grant/award (A): 80,472 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 8,549 @ $5.06 | EDGAR |
| 2026-01-20 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 1,581 @ $4.86 | EDGAR |
| 2025-10-29 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 896 @ $6.35 | EDGAR |
| 2025-08-18 | 4 | Aura Biosciences, Inc. (AURA) | Option exercise (M): 2,554 @ $5.07 · Option exercise (M): 1,094 @ $5.48 · Option exercise (M): 547 @ $5.48 · Option exercise (M): 547 @ $5.21 · Option exercise (M): 4,744 @ $2.74 · Option exercise (M): 1,094 @ $3.16 · +9 more | EDGAR |
| 2025-04-16 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 897 @ $5.49 | EDGAR |
| 2025-02-18 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 1,404 @ $7.75 | EDGAR |
| 2025-02-04 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 45,240 @ $0 · Grant/award (A): 29,760 (derivative) @ $0 | EDGAR |
| 2025-01-21 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 1,001 @ $7.67 | EDGAR |
| 2024-10-29 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 553 @ $10.74 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2042910 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →